AzTrials
AzTrials

Cerebral PalsyNCT02666560

Does Increasing Auditory Cueing Affect Gait Parameters in Children With Cerebral Palsy During a Functional Task?

A study testing Auditory Cueing in people with Cerebral Palsy and Children, run by Institute of Child Health.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

To determine the clinical efficacy of auditory cueing using a cross over design to investigate whether increasing auditory cueing frequency by 20% above self paced cadence affects gait parameters in children with Cerebral Palsy when performing a functional task. Read more about this study

Who is it for?
Ages 5 to 11 years
Conditions the study is for
Cerebral Palsy, Children
What is being tested?
Auditory Cueing
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
19 participants
Where
No sites listed yet
Study dates
Apr 2015to May 2015
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 5 to 11 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children with Cerebral Palsy aged 5 to 11 years old who were scored as levels 1 to 2 on the Gross Motor Function Classification Scale.
  • Cognitive status average or above on the Weschler Intelligence Scale for children.
  • Able to hear without the use of a hearing aid.

Who cannot join

  • Hearing impairment that results in the use of a hearing aid.
  • Walking with assistance of a mobility aid.
  • Cardiovascular problems or other associated health problems which limits the child waking multiple times over the GAITRite®.

About this study

To determine the clinical efficacy of auditory cueing using a cross over design to investigate whether increasing auditory cueing frequency by 20% above self paced cadence affects gait parameters in children with Cerebral Palsy when performing a functional task.

Read the detailed description

Introduction: Cerebral Palsy is a non progressive disorder occurring in early brain development, resulting in inefficient ambulatory pattern. The use of sensory cues to facilitate loco-motor activity has been suggested as providing the necessary trigger to synchronise movement with greater beneficial outcomes observed at higher frequency intensities within the adult population. Thus auditory cueing could have the potential to alter gait parameters during a functional task.

Aim: To explore if increasing auditory cueing frequency (AC20) affects gait during a functional task compared to auditory cueing at self-paced cadence (ACSC).

Method: Nineteen children with CP levels 1 and 2 on the Gross Motor Function Classification Scale participated using paired analysis. Outcomes were compared to the mean values for temporal spatial gait data within the conditions using a cross over design. TS data was obtained by using the GAITRite® walkway system whilst walking holding a cup.

Being tested
Auditory Cueing
Keywords
Auditory Cueing, Gait
Medical subject headings
Cerebral Palsy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Auditory CueingDevice

    Auditory cueing set at different frequency rates

Study groups in NCT02666560
Study groupRoleWhat they receive
Auditory cueing at self paced cadenceActive comparatorParticipants performed a functional task with auditory cueing set at self paced cadence.
Receives: Device: Auditory Cueing
Cueing at 20% above self paced cadenceExperimentalParticipants performed a functional task with auditory cueing set at 20% above self paced cadence whilst performing a functional task.
Receives: Device: Auditory Cueing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Step Length as Measured by the Gaitrite Walk-way System.

    The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. The temprospatial measure of length was recorded in centimetres.

    Measured: Data was collected at a single time point for each condition. Conditions occurred within a two week time period.

Secondary outcomes (5)
  1. Velocity as Measured by the Gaitrite Walk-way System.

    The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. The temprospatial measure of velocity was recorded in cm's per second.

    Measured: Data was collected at a single time point for each condition. Conditions occurred within a two week time period.

  2. Step Time as Measured by the Gaitrite Walk-way System.

    The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. The temprospatial measure of step time was recorded in seconds.

    Measured: Data was collected at a single time point for each condition. Conditions occurred within a two week time period.

  3. Cadence as Measured by the Gaitrite Walk-way System.

    The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. The temprospatial measure of cadence was recorded in steps per minute.

    Measured: Data was collected at a single time point for each condition. Conditions occurred within a two week time period.

  4. Time Spent in Double Support as Measured by the Gaitrite Walk-way System.

    The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. This was record in percentage of time spent in double support (%).

    Measured: Data was collected at a single time point for each condition. Conditions occurred within a two week time period.

  5. Time Spent in Single Support as Measured by the Gaitrite Walk-way System.

    The Gaitrite is a portable gait analysis walk-way system that enables the temprospatial measures of gait to be recorded. This was record in percentage of time spent in double support (%).

    Measured: Data was collected at a single time point for each condition. Conditions occurred within a two week time period.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jan 2016 (estimated)
  2. Study startApr 2015
  3. Primary completionMay 2015
  4. Study completionMay 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
19 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02666560
Sponsor's protocol ID
141A22
Status last verified
Apr 2016
First submitted
7 Jan 2016
Last updated
31 Aug 2016
Data monitoring committee
No
Individual data sharing
No

Publications

  • Rosenbaum PL, Walter SD, Hanna SE, Palisano RJ, Russell DJ, Raina P, Wood E, Bartlett DJ, Galuppi BE. Prognosis for gross motor function in cerebral palsy: creation of motor development curves. JAMA. 2002 Sep 18;288(11):1357-63. doi: 10.1001/jama.288.11.1357.

    PubMed 12234229
  • Kwak, E. (2007) Effect of rhythmic auditory stimulation on controlling stepping cadence of individuals with mental retardation and cerebral palsy. International journal of special education, vol 27, no 3, pp. 1-8.

  • Kim SJ, Kwak EE, Park ES, Lee DS, Kim KJ, Song JE, Cho SR. Changes in gait patterns with rhythmic auditory stimulation in adults with cerebral palsy. NeuroRehabilitation. 2011;29(3):233-41. doi: 10.3233/NRE-2011-0698.

    PubMed 22142756

Questions about this trial

What is this clinical trial studying?

A study testing Auditory Cueing in people with Cerebral Palsy and Children, run by Institute of Child Health.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Aug 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 31 Aug 2016). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Step Length as Measured by the Gaitrite Walk-way System. (time frame: Data was collected at a single time point for each condition. Conditions occurred within a two week time period.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02666560, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Aug 2016.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in